Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer
Cancer Medicine · 2024
DOI: 10.1002/cam4.6797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Sharath Kumar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India. Hauptthemen laut MEDLINE: Potentially Inappropriate Medication List, Neoplasms, Inappropriate Prescribing, Polypharmacy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polypharmacy and potentially inappropriate medication (PIM) use are common problems in older adults. Safe prescription practices are a necessity. The tools employed for the identification of PIM sometimes do not concur with each other.
Methods
A retrospective analysis of patients ≥60 years who visited the Geriatric Oncology Clinic of the Tata Memorial Hospital, Mumbai, India from 2018 to 2021 was performed. Beer's‐2015, STOPP/START criteria v2, PRISCUS‐2010, Fit fOR The Aged (FORTA)‐2018, and the EU(7)‐PIM list‐2015 were the tools used to assess PIM. Every patient was assigned a standardized PIM value (SPV) for each scale, which represented the ratio of the number of PIMs identified by a given scale to the total number of medications taken. The median SPV of all five tools was considered the reference standard for each patient. Bland–Altman plots were utilized to determine agreement between each scale and the reference. Association between baseline variables and PIM use was determined using multiple logistic regression analysis.
Results
Of the 467 patients included in this analysis, there were 372 (79.66%) males and 95 (20.34%) females with an average age of 70 ± 5.91 years. The EU(7)‐PIM list was found to have the highest level of agreement given by a bias estimate of 0.010, the lowest compared to any other scale. The 95% CI of the bias was in the narrow range of −0.001 to 0.022, demonstrating the precision of the estimate. In comparison, the bias (95%) CI of Beer's criteria, STOPP/START criteria, PRISCUS list, and FORTA list were −0.039 (−0.053 to −0.025), 0.076 (0.060 to 0.092), 0.035 (0.021 to 0.049), and −0.148 (−0.165 to −0.130), respectively. Patients on polypharmacy had significantly higher PIM use compared to those without (OR = 1.47 (1.33–1.63), p =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
- Department of Statistics, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
- Homi Bhabha National Institute, Mumbai, India.
- Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
ORCID-Profile: Kumar Prabhash, Vikram Gota
Zitieren
APA
Kumar, S., Castelino, R., Rao, A., Gattani, S., Kumar, A., Pillai, A., Sehgal, A., Rane, P., Ramaswamy, A., Dhekale, R., Krishnamurthy, J., Banavali, S., Badwe, R., Prabhash, K., Noronha, V., & Gota, V. (2024). Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer. Cancer Medicine. https://doi.org/10.1002/cam4.6797
Vancouver
Kumar S, Castelino R, Rao A, Gattani S, Kumar A, Pillai A, et al. Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer. Cancer Medicine. 2024. doi:10.1002/cam4.6797
BibTeX
@article{Kumar2024,
author = {Kumar, Sharath and Castelino, Renita and Rao, Abhijith and Gattani, Shreya and Kumar, Anita and Pillai, Anupa and Sehgal, Arshiya and Rane, Pallavi and Ramaswamy, Anant and Dhekale, Ratan and Krishnamurthy, Jyoti and Banavali, Shripad and Badwe, Rajendra and Prabhash, Kumar and Noronha, Vanita and Gota, Vikram},
title = {Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6797}
}
EUVIMED